Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 6 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Esophageal Squamous Cell Carcinoma 4 Pancreatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Nasopharyngeal Neoplasms 2 Uterine Cervical Dysplasia 1 Solid Tumors 1 Solid Tumor 1 Recurrence 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Diseases 1 NSCLC 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 HCC 1 Esophageal Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Childhood Brain Stem Neoplasm 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Colorectal Cancer 1 Advanced Cancer 1

Interventions

Taxes 3 S 1 (combination) 3 Gemcitabine 3 Drug Therapy 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 pegylated granulocyte colony-stimulating factor 1 nimotuzumab 1 envafolimab 1 endostar protein 1 conteltinib 1 apatinib 1 Radiosurgery 1 Nivolumab 1 Immunotherapy 1 Endostatins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Pancreatic Cancer × nimotuzumab × Clear all

NCT06422156 2024-05-20

Nim-PC-28

Peking University Third Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡